These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31489324)

  • 41. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Singal AG; Lim JK; Kanwal F
    Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Piñero F; Rubinstein F; Marciano S; Fernández N; Silva J; Zambelo Y; Anders M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Silva M
    Dig Dis Sci; 2019 Mar; 64(3):718-728. PubMed ID: 30511199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
    Toyoda H; Kumada T; Tada T; Mizuno K; Hiraoka A; Tsuji K; Ishikawa T; Akita T; Tanaka J
    Liver Int; 2018 Dec; 38(12):2260-2268. PubMed ID: 29981527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification.
    Lee M; Chang Y; Oh S; Cho YY; Jung DE; Kim HH; Nam JY; Cho H; Cho EJ; Lee JH; Yu SJ; Yi NJ; Lee KW; Lee DH; Lee JM; Yoon JH; Suh KS; Kim YJ
    Gut Liver; 2018 Sep; 12(5):571-582. PubMed ID: 29730905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study.
    Kennedy NA; Rodgers A; Altus R; McCormick R; Wundke R; Wigg AJ
    Intern Med J; 2013 Jul; 43(7):772-7. PubMed ID: 23611607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.
    Cucchetti A; Trevisani F; Pecorelli A; Erroi V; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Giannini EG; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Baroni GS; Virdone R; Bernardi M; Pinna AD;
    J Hepatol; 2014 Aug; 61(2):333-41. PubMed ID: 24717522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular Carcinoma Surveillance-Experience from Croatian Referral Centre for Chronic Liver Diseases.
    Majerović M; Jelaković M; Premužić M; Štromar IK; Radić D; Mance M; Pleština S; Ostojić R; Rustemović N; Krznarić Z
    J Gastrointest Cancer; 2019 Mar; 50(1):48-53. PubMed ID: 29127665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
    Wong LL; Reyes RJ; Kwee SA; Hernandez BY; Kalathil SC; Tsai NC
    Clin Mol Hepatol; 2017 Sep; 23(3):239-248. PubMed ID: 28706177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Liu D; Chan AC; Fong DY; Lo CM; Khong PL
    Transplantation; 2017 Jan; 101(1):107-111. PubMed ID: 28009758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
    Bucci L; Garuti F; Lenzi B; Pecorelli A; Farinati F; Giannini EG; Granito A; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Cammà C; Virdone R; Marra F; Felder M; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Colecchia A; Bernardi M; Trevisani F;
    Liver Int; 2017 Feb; 37(2):259-270. PubMed ID: 27427866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States.
    Liu P; Xie SH; Hu S; Cheng X; Gao T; Zhang C; Song Z
    Oncotarget; 2017 Sep; 8(40):68131-68137. PubMed ID: 28978103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study.
    De Santis A; Iegri C; Kondili L; Riggio O; Salvatori FM; Catalano C; Di Martino M; Bassanelli C; Lupo M; Lucatelli P; Attili AF
    Dig Liver Dis; 2014 Aug; 46(8):726-30. PubMed ID: 24893685
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.